Unknown

Dataset Information

0

Antibody and T cell response to a third dose of SARS-CoV-2 messenger RNA BNT162b2 vaccine in kidney transplant recipients.

ABSTRACT:

SUBMITTER: Bertrand D 

PROVIDER: S-EPMC8489274 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience.
| S-EPMC8397500 | biostudies-literature
Unknown Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
| S-EPMC8385563 | biostudies-literature
Unknown Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.
| S-EPMC8091803 | biostudies-literature
Unknown Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT.
| S-EPMC8415894 | biostudies-literature
Unknown Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
| S-EPMC8689434 | biostudies-literature
Unknown The SARS-CoV-2-neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine.
| S-EPMC8450277 | biostudies-literature
Unknown Antibody response to 2- and 3-dose SARS-CoV-2 mRNA vaccination in pediatric and adolescent kidney transplant recipients.
| S-EPMC9244318 | biostudies-literature
Unknown Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients.
| S-EPMC8222867 | biostudies-literature
Unknown The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patients.
| S-EPMC8853982 | biostudies-literature
Unknown Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study).
| S-EPMC8506046 | biostudies-literature